Sinema’s office did not respond to a request for comment.
The pharmaceutical industry has spent millions of dollars on ads and lobbying to fight new rules and regulations that would amount to hundreds of billions of dollars in savings for the government — and consequential losses for the industry’s bottom line.
Her individual donors also included a who’s who of powerful people in the pharmaceutical industry. Top donors included the pharma giant Gilead’s CEO, Daniel O’Day, who gave $5,000 this past quarter. Another $2,900 came in from Eli Lilly CEO David Ricks. The executive chair of Merck’s board, Kenneth C. Frazier, also gave $2,900, as did the chair and CEO of Bristol Myers Squibb, Giovanni Caforio. The CEO of Genentech, Alexander Hardy, gave $2,500. Meanwhile, the Pharmaceutical Research and Manufacturers of America’s executive vice president for policy and research Jennifer Bryant, senior vice president for federal advocacy Anne Esposito, and executive vice president for public affairs Debra DeShong each gave $1,000.
Little of the $1.1 million Sinema raised came from her constituents. Nearly 90 percent of Sinema’s cash from individual contributors came from outside Arizona.
Sinema is not up for reelection until 2024. But her campaign account has been a landing spot for donors nonetheless. Sinema never raised more than $700,000 in a quarter during the last Congress, but she has now topped $1 million twice in the last two quarters of 2021.
PACs for the financial services industry — another sector facing potential new regulation in Congress — gave more than $50,000, according to Sinema’s campaign filing. Goldman Sachs president John Waldron made a maximum donation of $5,800. Two senior managing directors at Blackstone — Giovanni Cutaia and Eli Nagler — collectively gave $5,700, and a managing director of government relations there, Alex Katz, donated $1,000. The Winklevoss twins, the American investors who battled with Mark Zuckerberg over the founding of Facebook and gained wider fame from the movie “The Social Network,” both maxed out to Sinema this quarter. The brothers are involved in cryptocurrency, a field that falls under the jurisdiction of the Senate Banking’s Subcommittee on Financial Institutions and Consumer Protection, on which Sinema sits.
Sinema’s role in negotiating down President Joe Biden’s agenda has brought her ire from the party’s progressive activists. Recently, groups of protesters followed her into the bathroom and traveled to the Boston Marathon race — which Sinema did not run — to advocate for the Biden administration’s spending plans.
Read More: Sinema rakes in Pharma and finance cash amid reconciliation negotiations